PEGBIO
Founded in 2008, Suzhou city-based PegBio is a bio-pharmaceutical company specializing in the development of innovative drugs to combat diabetes and obesity. Its key product PB-119, an agonist of glucagon-like peptide 1 (GLP-1), allows diabetes patients to take medicine once a week, instead of requiring daily injections.
PEGBIO
Industry:
Health Care Pharmaceutical
Founded:
2008-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.pegbio.com
Total Employee:
11+
Status:
Active
Contact:
0512-62956128
Email Addresses:
[email protected]
Total Funding:
23.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Mobile Non Scaleable Content ASP.NET Apple Mobile Web App Capable Apple Mobile Web App Status Bar Style China Telecom Bootcss Micro_httpd
Similar Organizations
DrugStoc
DrugStoc is an innovative drug procurement platform.
Purple Biotech
Purple Biotech is an innovative biopharmaceutical drug development company.
Virogin Biotech
Virogin Biotech is an antineoplastic drug developer.
Current Employees Featured
Founder
Investors List
Tasly Holding Group
Tasly Holding Group investment in Series E - PegBio
Legend Capital
Legend Capital investment in Series D - PegBio
ShareLink Capital
ShareLink Capital investment in Series D - PegBio
Mingxin China Growth Fund
Mingxin China Growth Fund investment in Series C - PegBio
Oriza Seed Capital (Oriza Yuandian)
Oriza Seed Capital (Oriza Yuandian) investment in Series C - PegBio
Cowin Venture
Cowin Venture investment in Series B - PegBio
Legend Star
Legend Star investment in Series A - PegBio
Official Site Inspections
http://www.pegbio.com
- Host name: 59.56.106.142
- IP address: 59.56.106.142
- Location: China
- Latitude: 24.4798
- Longitude: 118.0819
- Timezone: Asia/Shanghai
